Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-13-046275)

Filing Details

Accession Number:: 0001104659-13-046275
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-06-03 07:59:33
Reporting Period:: 2013-05-29

Filing Date:: 2013-06-03
Accepted Time:: 2013-06-03 07:59:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1264587	Stemline Therapeutics Inc	STML	Pharmaceutical Preparations (2834)	450522567

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1007923	J Kenneth Zuerblis	C/O Stemline Therapeutics, Inc. 750 Lexington Avenue, Sixth Floor New York NY 10022		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-05-29	600	$15.85	8,563	No	4	P	Indirect	By IRA
Common Stock	Acquisiton	2013-05-29	500	$15.86	9,063	No	4	P	Indirect	By IRA
Common Stock	Acquisiton	2013-05-29	1,000	$15.86	10,063	No	4	P	Indirect	By Son
Common Stock	Acquisiton	2013-05-30	200	$16.38	10,263	No	4	P	Indirect	By Spouse IRA
Common Stock	Acquisiton	2013-05-30	700	$16.38	10,963	No	4	P	Indirect	By IRA

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By IRA
No	4	P	Indirect	By IRA
No	4	P	Indirect	By Son
No	4	P	Indirect	By Spouse IRA
No	4	P	Indirect	By IRA

Footnotes

Of the 8,563 shares, 3,982 are shares of restricted stock.
Of the 9,063 shares, 3,982 are shares of restricted stock.
Of the 10,063 shares, 3,982 are shares of restricted stock.
Of the 10,263 shares, 3,982 are shares of restricted stock.
Of the 10,963 shares, 3,982 are shares of restricted stock.